Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers World Congress 2016

Circulating Biomarkers World Congress 2016

Date: Monday, 21 March 2016 - Tuesday, 22 March 2016
Location: Boston, USA


Keynote Speakers

Phil Stephens

Phil Stephens
Chief Scientific Officer, Foundation Medicine

Shannon Stott

Shannon Stott
Assistant Professor, Massachusetts General Hospital & Harvard Medical School

John Palma

John Palma
Director, Medical & Scientific Affairs, Roche Molecular Systems

Gyongyi Szabo

Gyongyi Szabo
Professor, University of Massachusetts Medical School

Joshua Levin

Joshua Levin
Senior Scientist/Group Leader, The Broad Institute of MIT and Harvard

Frank Slack

Frank Slack
Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School

Stefan Momma

Stefan Momma
Group Leader, University Hospital Frankfurt

Clark Chen

Clark Chen
Co-Director, University of California-San Diego

Chwee Teck Lim

Chwee Teck Lim
Provost’s Chair Professor, National University of Singapore

Bob Carter

Bob Carter
Professor and Chair, UCSD Neurosurgery

Steve Soper

Steve Soper
Professor/Director, University of North Carolina-Chapel Hill

Saumya Das

Saumya Das
Assistant Professor, Harvard Medical School

Shana Kelley

Shana Kelley
Professor, University of Toronto

Xandra Breakefield

Xandra Breakefield
Professor, Harvard Medical School

Peter  Quesenberry

Peter Quesenberry
Professor of Medicine, The Warren Alpert Medical School of Brown University

Overview

The 3rd. Annual SELECTBIO Circulating Biomarkers World Congress 2016 brings together academic researchers as well as industry participants to present and discuss the most up-to-date research and commercial activities in the translation of various circulating biomarker classes towards the clinic.

This Congress discusses Nucleic Acid-based Biomarkers, Protein-based Biomarkers, Extracellular Vesicle (EV)-based Biomarkers (contained within exosomes and microvesicles), and Circulating Tumor Cell (CTC)-based Biomarkers.

One of the conference tracks focuses on Liquid Biopsies as the fields of Circulating Biomarkers and Liquid Biopsy development are converging and the various classes of Circulating Biomarkers may be developed into liquid biopsies for cancer and several other disease classes.

A co-located exhibit hall features companies developing technologies and products for the complete workflow from sample isolation, preparation, through data analysis.

Conference delegates receive access to all three co-located conference tracks, can mix-and-match presentations from all three tracks thereby maximizing the conference experience, and can network with delegates from the various co-located tracks and exhibition.

Corporate Sponsors Media Sponsors Networking
U-Networks

Add to Calendar ▼2016-03-21 00:00:002016-03-22 00:00:00Europe/LondonCirculating Biomarkers World Congress 2016Circulating Biomarkers World Congress 2016 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com